3 Healthcare Stocks Generating Trading Interest as Earnings are Digested

Becton Dickinson and Company (NYSE:BDX) reported its results for the second quarter. Net income for Becton Dickinson and Company fell to $291 million ($1.38 per share) vs. $312 million ($1.38 per share) a year earlier. This is a decline of 6.7% from the year-earlier quarter. Revenue rose 3.6% to $1.99 billion from the year-earlier quarter. Becton Dickinson and Company fell in line with the mean analyst estimate of $1.38 per share. It beat the average revenue estimate of $1.94 billion.

Biogen Idec Inc. (NASDAQ:BIIB) reported its results for the first quarter. Net income for the medical-bioengineering rose to $302.7 million ($1.25 per share) vs. $294.3 million ($1.20 per share) in the same quarter a year earlier. This marks a rise of 2.8% from the year-earlier quarter. Revenue rose 7.4% to $1.29 billion from the year-earlier quarter. Biogen Idec Inc. fell short of the mean analyst estimate of $1.44 per share. Analysts were expecting revenue of $1.31 billion.

Davita Inc. (NYSE:DVA) reported its results for the first quarter. Net income for Davita Inc. rose to $140.1 million ($1.46 per share) vs. $94.5 million (96 cents per share) in the same quarter a year earlier. This marks a rise of 48.3% from the year-earlier quarter. Revenue rose 19.5% to $1.87 billion from the year-earlier quarter. Davita Inc. was about in line with expectations as the mean analyst estimate of $1.45 per share. Analysts were expecting revenue of $1.85 billion.